Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALB vs GSK✓SelectedUSD · GSKALB vs GSK performance historyLatest closeAs of-0.56%11/17
Stock and ETF performance explorer

ALB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-65.9%
GSK return
+43.9%
Excess return
-109.8%
Maximum drawdown
-83.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.6%-2.3%+1.8%-0.1%
7D-7.6%-3.0%-4.6%-7.1%
30D-8.2%+0.4%-8.5%-8.3%
3M-34.3%-1.2%-33.2%-34.3%
6M-51.1%+0.9%-52.0%-51.4%
YTD-37.5%+4.0%-41.5%-38.5%
1Y-24.7%+7.3%-32.0%-26.3%
3Y-27.9%+57.1%-84.9%-36.2%
5Y-65.9%+43.0%-108.9%-71.5%
All-65.9%+43.9%-109.8%-71.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling